Metastatic Prostate Cancer Clinical Trials in Baltimore, Maryland

4 studies are recruiting for metastatic prostate cancer in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Study of ORIC-944 in Patients With Metastatic Prostate Cancer

    The purpose of this study is to establish the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate cancer.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Marlene & Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland
    Locations
    27 in total
    Run by
    ORIC Pharmaceuticals

    See if you can join NCT05413421 on ClinicalTrials.gov

  2. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    This is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in improving the castration-resistant prostate cancer-free survival (CRPC-free survival) for Veterans with oligometastatic pros…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD, Baltimore, Maryland
    Locations
    20 in total
    Run by
    VA Office of Research and Development

    See if you can join NCT04787744 on ClinicalTrials.gov

  3. Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer

    To determine if dexamethasone or dexamethasone plus metronidazole restore sensitivity to abiraterone for the treatment of metastatic prostate cancer.

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
    Run by
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    See if you can join NCT06616597 on ClinicalTrials.gov

  4. Physician- and Patient-based Barriers to NGS Testing

    The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
    Run by
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    See if you can join NCT07209176 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.